Mucosal immunologic responses in cholera patients in Bangladesh.
Vibrio cholerae O1 causes dehydrating diarrhea with a high mortality rate if untreated. The infection also elicits long-term protective immunity. Since V. cholerae is noninvasive, mucosal immunity is likely important for protection. In this study, we compared humoral immune responses in the duodenal mucosa and blood of cholera patients at different time points after the onset of disease and compared them with those of healthy controls (HCs). Immune responses to lipopolysaccharide (LPS) and the recombinant cholera toxin B subunit (rCTB) were assessed by enzyme-linked immunosorbent assay (ELISA) and enzyme-linked immunospot (ELISPOT) assay. Significant increases in V. cholerae LPS-specific IgA and IgG antibody levels were seen in duodenal extracts on day 30, but the levels decreased to baseline by day 180; plasma V. cholerae LPS-specific IgA levels remained elevated longer. Levels of mucosal CTB antibodies also peaked on day 30, but the increase reached statistical significance only for IgG. A significant correlation was found between the CTB antibody-secreting cell (ASC) response in the circulatory system on day 7 and subsequent CTB-specific IgA levels in duodenal extracts on day 30 and the numbers of CTB-specific IgA ASCs in duodenal tissues on day 180. The proportion (0.07%) of mucosal V. cholerae LPS IgA ASCs peaked on day 30 and remained elevated through day 180 compared to that of HCs (P = 0.03). These results suggest that protective immunity against V. cholerae is not likely mediated by the constitutive secretion of antibodies at the mucosal surface; our results are consistent with those of other studies that suggest instead that anamnestic immune responses of mucosal lymphocytes may play a major role in protection against cholera.
International Centre for Diarrhoeal Disease Research, Bangladesh, Centre for Health and Population Research, Dhaka, Bangladesh.
Taher
T
Uddin
Jason B
JB
Harris
Taufiqur Rahman
TR
Bhuiyan
Tahmina
T
Shirin
Muhammad Ikhtear
MI
Uddin
Ashraful Islam
AI
Khan
Fahima
F
Chowdhury
Regina C
RC
LaRocque
Nur Haque
NH
Alam
Edward T
ET
Ryan
Stephen B
SB
Calderwood
Firdausi
F
Qadri
D000328:Adult; D000907:Antibodies, Bacterial / Q000032:analysis* / Q000097:blood*; D001459:Bangladesh; D002771:Cholera / Q000276:immunology* / Q000382:microbiology; D004386:Duodenum / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis / Q000097:blood; D007074:Immunoglobulin G / Q000032:analysis / Q000097:blood; D007413:Intestinal Mucosa / Q000276:immunology*; D008297:Male; D013997:Time Factors; D041241:Vibrio cholerae O1 / Q000276:immunology*
D000907:Antibodies, Bacterial; D007070:Immunoglobulin A; D007074:Immunoglobulin G
Nat Rev Microbiol. 2009 Oct;7(10):693-702
19756008
FEMS Immunol Med Microbiol. 2008 Oct;54(1):70-9
18625017
J Immunol Methods. 2000 Feb 3;234(1-2):51-9
10669769
J Infect Dis. 1998 Jun;177(6):1594-9
9607838
Infect Immun. 2009 Nov;77(11):5090-6
19703973
Infect Immun. 2009 Sep;77(9):3850-6
19528207
Am J Epidemiol. 1982 Dec;116(6):959-70
7148820
Infect Immun. 1997 Sep;65(9):3571-6
9284121
J Infect Dis. 1981 Jun;143(6):818-20
7252264
Annu Rev Immunol. 2010;28:243-73
20192805
Clin Diagn Lab Immunol. 1999 Nov;6(6):812-8
10548569
J Immunol. 2007 May 1;178(9):5612-22
17442944
Nat Rev Immunol. 2008 Jun;8(6):421-34
18483500
Vaccine. 2009 Feb 25;27(9):1386-92
19146897
PLoS Negl Trop Dis. 2008 Apr 09;2(4):e221
18398491
Infect Immun. 2009 May;77(5):1888-93
19237532
J Infect Dis. 1984 Jun;149(6):884-93
6736680
J Infect Dis. 2004 Jun 15;189(12):2318-22
15181581
Vaccine. 2003 Jun 2;21(19-20):2394-403
12744870
J Clin Invest. 1991 Jul;88(1):143-8
1905327
Infect Immun. 2005 Jan;73(1):523-31
15618192
Proc Biol Sci. 2005 May 7;272(1566):971-7
16024354
Infect Immun. 1992 Jul;60(7):2605-11
1612730
Vaccine. 2010 Jul 26;28(33):5445-50
20547203